Market Cap

Tissue Regenix Group plc Market Capitalization:

£51,645

GBP as of Jan. 1, 2026

US$69,505

business Tissue Regenix Group plc Company Profile

Tissue Regenix Group plc Main Stock Listing

LSE: TRX

Market Capitalization History of Tissue Regenix Group plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Tissue Regenix Group plc market cap

Date Market Cap YoY Change
Jan. 1, 2026 £51,645 -99.87%
Jan. 1, 2025 £40.6 M 10.64%
Jan. 1, 2024 £36.7 M -23.29%
Jan. 1, 2023 £47.8 M 45.16%
Jan. 1, 2022 £33.0 M -13.89%
Jan. 1, 2021 £38.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Tissue Regenix Group plc Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

Tissue Regenix Group plc has the following listings and related stock indices.


Stock: LSE: TRX

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.